PLPP2
Phospholipid phosphatase 2
Also known as: LPP2, PAP-2c, PLPP2_HUMAN, PPAP2C
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43688
- Gene
- PLPP2
- Ensembl
- ENSG00000141934
- Chromosome
- 19
- Canonical length
- 288 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the phosphatidic acid phosphatase (PAP) family. PAPs convert phosphatidic acid to diacylglycerol, and function in de novo synthesis of glycerolipids as well as in receptor-activated signal transduction mediated by phospholipase D. This protein is similar to phosphatidic acid phosphatase type 2A (PPAP2A) and type 2B (PPAP2B). All three proteins contain 6 transmembrane regions, and a consensus N-glycosylation site. This protein has been shown to possess membrane associated PAP activity. Three alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
288 residues, UniProt reviewed canonical sequence.
>O43688|PLPP2
1 MQRRWVFVLL DVLCLLVASL PFAILTLVNA PYKRGFYCGD DSIRYPYRPD TITHGLMAGV
61 TITATVILVS AGEAYLVYTD RLYSRSDFNN YVAAVYKVLG TFLFGAAVSQ SLTDLAKYMI
121 GRLRPNFLAV CDPDWSRVNC SVYVQLEKVC RGNPADVTEA RLSFYSGHSS FGMYCMVFLA
181 LYVQARLCWK WARLLRPTVQ FFLVAFALYV GYTRVSDYKH HWSDVLVGLL QGALVAALTV
241 CYISDFFKAR PPQHCLKEEE LERKPSLSLT LTLGEADHNH YGYPHSSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLPP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 104 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 104 nTPM
- spinal cord: 78 nTPM
- fallopian tube: 77 nTPM
- cervix: 60 nTPM
- duodenum: 59 nTPM
- skin: 53 nTPM
Single-cell type
- fallopian tube ciliated cells: 299 nCPM
- respiratory ciliated cells: 298 nCPM
- respiratory secretory cells: 249 nCPM
- breast secretory cells: 227 nCPM
- submucosal glandular cells: 222 nCPM
- cholangiocytes: 219 nCPM
Immune cell
- MAIT T-cell: 6.6 nTPM
- gdT-cell: 3.3 nTPM
- memory CD8 T-cell: 1.6 nTPM
- memory CD4 T-cell: 1.4 nTPM
- total PBMC: 0.3 nTPM
- naive CD8 T-cell: 0.1 nTPM
Brain region
- white matter: 122 nTPM
- basal ganglia: 78 nTPM
- medulla oblongata: 71 nTPM
- cerebellum: 70 nTPM
- cerebral cortex: 63 nTPM
- midbrain: 63 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ceramide metabolic process
- phospholipid dephosphorylation
- phospholipid metabolic process
- signal transduction
- sphingolipid catabolic process
- sphingosine metabolic process
Molecular functions
- ceramide-1-phosphate phosphatase activity
- phosphatidate phosphatase activity
- sphingosine-1-phosphate phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLPP2 as an antibody target. Whether an autoantibody or antibody against PLPP2 could matter depends on whether native PLPP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLPP2 is annotated at the cell surface, where native PLPP2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PLPP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...